Dysregulated Erythroid Mg²⁺ Efflux in Type 2 Diabetes

Area of Science:

• Biochemistry
• Cell Biology
• Physiology

Background:

• Hyperglycemia is linked to reduced magnesium (Mg2+) in red blood cells (RBCs), but the underlying mechanisms are not fully understood.
• Understanding RBC Mg2+ regulation is crucial for managing conditions like type 2 diabetes (T2D).

Purpose of the Study:

• To investigate the mechanisms regulating Mg2+ efflux from human RBCs in response to glucose.
• To explore the role of Na+/Mg2+ exchange, Src family kinases, and N-glycosylation in glucose-induced Mg2+ changes in RBCs.

Main Methods:

• Ex vivo characterization of Mg2+ efflux in human RBCs treated with D-glucose or sorbitol.
• Assessment of Na+/Mg2+ exchange activity using flux assays.
• Inhibition of Src family kinases (PP2, SU6656) and enzymatic deglycosylation (PNGase F).
• Comparison of RBCs from individuals with T2D and non-diabetic controls, as well as the db/db mouse model.

Main Results:

• D-glucose, but not sorbitol, significantly reduced total cellular Mg and enhanced Na+/Mg2+ exchange activity in human RBCs.
• Src family kinase inhibitors attenuated glucose-stimulated Na+/Mg2+ exchange.
• RBCs from individuals with T2D and db/db mice exhibited higher Na+/Mg2+ exchange activity and lower intracellular Mg content compared to controls.
• PNGase F treatment in T2D RBCs reduced Na+/Mg2+ exchange activity and restored intracellular Mg levels.

Conclusions:

• Enhanced Na+/Mg2+ exchange, regulated by Src family kinases and N-glycosylation of membrane proteins, contributes to reduced RBC Mg2+ content in T2D.
• These findings provide novel insights into the dysregulation of RBC Mg2+ homeostasis in hyperglycemia and T2D.